AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...

EV ExplainersWhat are electric vehicles all about? Get your questions answered by The Driven. We explain what electric vehicles are available, how to charge electric vehicles, and answer your ...

SAN DIEGO – Dexcom is recalling certain Dexcom G6, G7, ONE, and ONE+ glucose monitoring receivers because of a problem with the speaker that may cause it to fail to make an alert sound when blood ...

Tandem’s much-awaited Mobi automated insulin delivery system is available in the U.S. The Tandem Mobi is the world’s smallest insulin delivery system to be fully controllable by a smartphone. Now with ...

Chinese marque XPeng has launched its first model as a factory-backed operation in Australia, with the updated G6 electric vehicle (EV) the first salvo in trying to steal sales away from Tesla. Though ...

The global CGM market is projected to reach a valuation of $15.69bn in 2035, as per GlobalData analysis. Credit: Around the World Photos / Shutterstock.com The US Food and Drug Administration (FDA) ...

So you’ve connected a device to your PC via a USB port — but Windows doesn’t recognize it. What now? Before you assume the product (or your PC port) is broken, there are several USB troubleshooting ...

China's Xpeng has released initial details for its factory-backed relaunch in Australia, starting with the refreshed G6 SUV due to launch on July 1, 2026. The 2026 Xpeng G6 range is headlined by an ...

One year after hosting the G7 summit in Alberta, Prime Minister Mark Carney is set to rejoin world leaders — including U.S. President Donald Trump — for their first meeting since the start of the U.S.

The 15-day G7 CGM in use. [Image courtesy of Dexcom] Nearly halfway through 2026, the milestones are already stacking up for continuous glucose monitor (CGM) maker Dexcom (Nadsaq:DXCM). Finally, last ...

The CONNECT trial, presented at the American Diabetes Association’s 2026 Scientific Sessions in New Orleans, found that 82% of adults with type 2 diabetes who used a Dexcom G7 improved their blood ...